据以色列i24News：加沙方面称，以色列空袭针对加沙城里米尔地区的一辆车，造成一人死亡，九人受伤。

China's National Medical Products Administration granted priority-review approval to Kaixing Life Sciences (Shanghai) Co. for Shurui Jiaolunsai injection, marketed as Kailimei, for CLDN18.2‑positive, HER2‑negative advanced gastric or gastroesophageal junction adenocarcinoma in patients who have progressed after at least two prior lines of therapy. The approval adds a new later‑line treatment option for this biomarker‑defined patient population.

MOFCOM, the NDRC and the Ministry of Finance issued an Action Plan to stabilise and improve foreign investment, prioritising domestic reinvestment by foreign firms. Key measures: implement tax preferences allowing overseas investors to directly reinvest distributed profits and ensure targeted delivery of those benefits; include more reinvestment projects in major/priority foreign‑investment project lists to expand service and support; and actively attract foreign firms to set up R&D centres in China by strengthening support policies, easing recruitment of foreign high‑level talent, supporting open innovation platforms, training bases and new‑model R&D institutions, increasing support for commercialising innovation, and allowing qualifying imported research supplies to receive import tax incentives.